Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;11(5):467-9.
doi: 10.7861/clinmedicine.11-5-467.

The new oral anticoagulants

K A Breen  1 , B J Hunt
Affiliations

The new oral anticoagulants

K A Breen et al. Clin Med (Lond). 2011 Oct.
No abstract available

PubMed Disclaimer

Comment in

References

    1. Yusuf S, Mehta SR, Chrolavicius S, et al. OASIS-6 Trial Group Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA 2006; 295: 1519–30 - PubMed
    1. Fitzmaurice DA, Gardiner C, Kitchen S, British Society of Haematology Taskforce for Haemostasis and Thrombosis An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. Br J Haematol 2005; 131: 156–65 10.1111/j.1365-2141.2005.05739.x - DOI - PubMed
    1. Gustafsson D, Elg M. The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. Thromb Res 2003; 109Suppl 1: S9–15 10.1016/S0049-3848(03)00249-4 - DOI - PubMed
    1. Eriksson BI, Dahl OE, Rosencher N, et al. RE-NOVATE Study Group Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 2007; 370: 949–56 10.1016/S0140-6736(07)61445-7 - DOI - PubMed
    1. Eriksson BI, Dahl OE, Rosencher N, et al. RE-MODEL Study Group Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007; 5: 2178–85 10.1111/j.1538-7836.2007.02748.x - DOI - PubMed

MeSH terms